Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes (Articolo in rivista)

Type

• Articolo in rivista (Classe)
• Prodotto della ricerca (Classe)

Label

• Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes (Articolo in rivista) (literal)

Anno

• 2008-01-01T00:00:00+01:00 (literal)

Alternative label

• D'Abusco A.S., Cicione C., Calamia V., Negri R., Giordano C., Grigolo B., Politi L., Scandurra R. (2008)
  Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes
  in Clinical and Experimental Rheumatology (Testo stamp.)
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• D'Abusco A.S., Cicione C., Calamia V., Negri R., Giordano C., Grigolo B., Politi L., Scandurra R. (literal)

Pagina inizio

• 847 (literal)

Pagina fine

• 852 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

• 25 (literal)

Rivista

• Clinical and Experimental Rheumatology (Rivista)

Note

• ISI Web of Science (WOS) (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

• 1. Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy 2. Univ Roma La Sapienza, Lab Funct Genom & proteom Model Syst, Rome, Italy 3. Univ Roma La Sapienza, CNR, Inst Biomol Chem, Rome, Italy 4. Univ Bologna, Inst Codivilla Putti, Lab Immunol & Genet, I-40126 Bologna, Italy (literal)

Titolo

• Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes (literal)

Abstract

• Glucosamine (GlcN) is used in the treatment of osteoarthritis as symptomatic slow-acting drug, but its mode of action is not completely known. We analyzed the influence of GlcN and its N-acetyl-phenylalanine derivative (NAPA) on mRNA transcription level of TNF-alpha-stimulated genes in cell culture. (literal)

Prodotto di

• Sintesi di nuovi farmaci per malattie neurodegenerative (PM.P01.010.002) (Modulo)
• Istituto di chimica biomolecolare (ICB) (Istituto)

Autore CNR

• CESARE GIOVANNI GIORDANO (Persona)

Insieme di parole chiave

• Parole chiave di "Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes" (Insieme di parole chiave)

Incoming links:

Autore CNR di

• CESARE GIOVANNI GIORDANO (Persona)

Prodotto

• Istituto di chimica biomolecolare (ICB) (Istituto)
• Sintesi di nuovi farmaci per malattie neurodegenerative (PM.P01.010.002) (Modulo)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• Clinical and Experimental Rheumatology (Rivista)

Insieme di parole chiave di

• Parole chiave di "Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes" (Insieme di parole chiave)